B. Riley Has Bearish Estimate for Hyperfine FY2025 Earnings

Hyperfine, Inc. (NASDAQ:HYPR) – Stock analysts at B. Riley lowered their FY2025 earnings estimates for shares of Hyperfine in a report issued on Monday, November 17th. B. Riley analyst Y. Zhi now anticipates that the company will post earnings of ($0.45) per share for the year, down from their previous forecast of ($0.43). The consensus estimate for Hyperfine’s current full-year earnings is ($0.57) per share. B. Riley also issued estimates for Hyperfine’s Q4 2025 earnings at ($0.08) EPS.

Hyperfine (NASDAQ:HYPR) last issued its earnings results on Thursday, November 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Hyperfine had a negative return on equity of 97.95% and a negative net margin of 378.17%.The company had revenue of $3.44 million for the quarter, compared to the consensus estimate of $3.51 million. Hyperfine has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

A number of other research analysts also recently weighed in on the company. Lake Street Capital upped their price target on Hyperfine from $1.50 to $2.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Wednesday, October 8th. Wall Street Zen raised Hyperfine from a “sell” rating to a “hold” rating in a research report on Saturday, October 25th. Finally, Wells Fargo & Company lifted their price objective on shares of Hyperfine from $0.68 to $0.85 and gave the stock an “equal weight” rating in a research report on Friday, August 15th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Hyperfine currently has an average rating of “Hold” and a consensus price target of $1.28.

Hyperfine Price Performance

HYPR stock opened at $1.07 on Wednesday. The company’s 50-day moving average is $1.38 and its 200-day moving average is $1.08. The stock has a market capitalization of $84.08 million, a PE ratio of -2.06 and a beta of 1.08. Hyperfine has a 1 year low of $0.53 and a 1 year high of $2.22.

Hedge Funds Weigh In On Hyperfine

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. EP Wealth Advisors LLC bought a new position in Hyperfine in the 1st quarter worth about $25,000. Tortoise Investment Management LLC bought a new stake in shares of Hyperfine during the 3rd quarter valued at about $65,000. Finally, Vanguard Group Inc. grew its holdings in shares of Hyperfine by 5.7% during the third quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock worth $5,092,000 after purchasing an additional 190,136 shares in the last quarter. 15.03% of the stock is currently owned by hedge funds and other institutional investors.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.